Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noiiglutide for weight loss in obese non-diabetic adults (Phase II)
CTR20210439Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Mar 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of noiiglutide in obesity, sponsored by Hengrui Therapeutics. Started Mar 2021; status: completed.
02
Drugs
noiiglutide
03
Conditions
obesity
Beyond the preview
Go deeper on CTR20210439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210439.